Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Pneumonia-Specific Escherichia coli with Distinct Phylogenetic and Virulence Profiles, France, 2012-2014.

La Combe B, Clermont O, Messika J, Eveillard M, Kouatchet A, Lasocki S, Corvec S, Lakhal K, Billard-Pomares T, Fernandes R, Armand-Lefevre L, Bourdon S, Reignier J, Fihman V, de Prost N, Bador J, Goret J, Wallet F, Denamur E, Ricard JD; COLOCOLI group; COLOCOLI Group.

Emerg Infect Dis. 2019 Apr;25(4):710-718. doi: 10.3201/eid2504.180944.

2.

The intestinal microbiota predisposes to traveler's diarrhea and to the carriage of multidrug-resistant Enterobacteriaceae after traveling to tropical regions.

Leo S, Lazarevic V, Gaïa N, Estellat C, Girard M, Matheron S, Armand-Lefèvre L, Andremont A The VOYAG-R study group, Schrenzel J, Ruppé E.

Gut Microbes. 2019;10(5):631-641. doi: 10.1080/19490976.2018.1564431. Epub 2019 Feb 3.

3.

A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trial.

Huttner BD, de Lastours V, Wassenberg M, Maharshak N, Mauris A, Galperine T, Zanichelli V, Kapel N, Bellanger A, Olearo F, Duval X, Armand-Lefevre L, Carmeli Y, Bonten M, Fantin B, Harbarth S; R-Gnosis WP3 study group.

Clin Microbiol Infect. 2019 Jul;25(7):830-838. doi: 10.1016/j.cmi.2018.12.009. Epub 2019 Jan 4.

4.

Acquisition of plasmid-mediated cephalosporinase producing Enterobacteriaceae after a travel to the tropics.

Lorme F, Maataoui N, Rondinaud E, Esposito-Farèse M, Clermont O, Ruppe E, Arlet G, Genel N; VOYAG-R study group, Matheron S, Andremont A, Armand-Lefevre L.

PLoS One. 2018 Dec 18;13(12):e0206909. doi: 10.1371/journal.pone.0206909. eCollection 2018.

5.

High acquisition rate of extended-spectrum β-lactamase-producing Enterobacteriaceae among French military personnel on mission abroad, without evidence of inter-individual transmission.

Maataoui N, Mayet A, Duron S, Delacour H, Mentré F, Laouenan C, Desvillechabrol D, Cokelaer T, Meynard JB, Ducher A, Andremont A, Armand-Lefèvre L, Mérens A.

Clin Microbiol Infect. 2019 May;25(5):631.e1-631.e9. doi: 10.1016/j.cmi.2018.07.030. Epub 2018 Aug 9.

PMID:
30099136
6.

High-dose daptomycin in patients with infective endocarditis or sternal wound infections.

Peiffer-Smadja N, Abbara S, Rizk N, Pogliaghi M, Rondinaud E, Tesmoingt C, Massias L, Lucet JC, Alkhoder S, Armand-Lefèvre L, Lescure FX.

Clin Microbiol Infect. 2018 Oct;24(10):1106-1108. doi: 10.1016/j.cmi.2018.05.015. Epub 2018 Jun 4. No abstract available.

7.

Thirteen-year experience with universal Staphylococcus aureus nasal decolonization prior to cardiac surgery: a quasi-experimental study.

Lemaignen A, Armand-Lefevre L, Birgand G, Mabileau G, Lolom I, Ghodbane W, Dilly MP, Nataf P, Lucet JC.

J Hosp Infect. 2018 Nov;100(3):322-328. doi: 10.1016/j.jhin.2018.04.023. Epub 2018 May 5.

PMID:
29733924
8.

Travel and acquisition of multidrug-resistant Enterobacteriaceae.

Armand-Lefèvre L, Andremont A, Ruppé E.

Med Mal Infect. 2018 Oct;48(7):431-441. doi: 10.1016/j.medmal.2018.02.005. Epub 2018 Mar 14. Review.

PMID:
29550142
9.

Prevalence of carriage of extended-spectrum β-lactamase-producing enterobacteria and associated factors in a French hospital.

Jolivet S, Vaillant L, Poncin T, Lolom I, Gaudonnet Y, Rondinaud E, Bendjelloul G, Lomont A, Lucet JC, Armand-Lefèvre L.

Clin Microbiol Infect. 2018 Dec;24(12):1311-1314. doi: 10.1016/j.cmi.2018.03.008. Epub 2018 Mar 13.

PMID:
29549056
10.

Decreased susceptibility to chlorhexidine affects a quarter of Escherichia coli isolates responsible for pneumonia in ICU patients.

La Combe B, Bleibtreu A, Messika J, Fernandes R, Clermont O, Branger C, Billard-Pomares T, Barnaud G, Magdoud F, Eveillard M, Kouatchet A, Lasocki S, Asfar P, Corvec S, Lakhal K, Armand-Lefevre L, Wolff M, Timsit JF, Bourdon S, Reignier J, Martin S, Fihman V, de Prost N, Bador J, Charles PE, Goret J, Boyer A, Wallet F, Jaillette E, Nseir S, Landraud L, Ruimy R, Danin PE, Dellamonica J, Cremniter J, Frat JP, Jauréguy F, Clec'h C, Decré D, Maury E, Dreyfuss D, Denamur E, Ricard JD.

Intensive Care Med. 2018 Apr;44(4):531-533. doi: 10.1007/s00134-018-5061-8. Epub 2018 Jan 29. No abstract available.

PMID:
29379992
11.

Protection of the Human Gut Microbiome From Antibiotics.

de Gunzburg J, Ghozlane A, Ducher A, Le Chatelier E, Duval X, Ruppé E, Armand-Lefevre L, Sablier-Gallis F, Burdet C, Alavoine L, Chachaty E, Augustin V, Varastet M, Levenez F, Kennedy S, Pons N, Mentré F, Andremont A.

J Infect Dis. 2018 Jan 30;217(4):628-636. doi: 10.1093/infdis/jix604.

12.

Digestive tract colonization by multidrug-resistant Enterobacteriaceae in travellers: An update.

Ruppé E, Andremont A, Armand-Lefèvre L.

Travel Med Infect Dis. 2018 Jan - Feb;21:28-35. doi: 10.1016/j.tmaid.2017.11.007. Epub 2017 Nov 17. Review.

PMID:
29155322
13.

Impact of antibiotics on the intestinal microbiota needs to be re-defined to optimize antibiotic usage.

Ruppé E, Burdet C, Grall N, de Lastours V, Lescure FX, Andremont A, Armand-Lefèvre L.

Clin Microbiol Infect. 2018 Jan;24(1):3-5. doi: 10.1016/j.cmi.2017.09.017. Epub 2017 Sep 29. No abstract available.

14.

Surgical site infection with extended-spectrum β-lactamase-producing Enterobacteriaceae after cardiac surgery: incidence and risk factors.

Jolivet S, Lescure FX, Armand-Lefevre L, Raffoul R, Dilly MP, Ghodbane W, Nataf P, Lucet JC.

Clin Microbiol Infect. 2018 Mar;24(3):283-288. doi: 10.1016/j.cmi.2017.07.004. Epub 2017 Jul 8.

15.

Prevalence of extended-spectrum beta-lactamase phenotypes in enterobacteria isolated from blood cultures of patients at admission to the University Hospital of Bamako.

Sangaré SA, Maïga AI, Maïga A, Diallo S, Camara N, Savadogo S, Guindo I, Bougoudogo F, Armand-Lefèvre L, Andremont A, Maïga II.

Med Sante Trop. 2017 Jun 1;27(2):170-175. doi: 10.1684/mst.2017.0681.

16.

Unexpected persistence of extended-spectrum β-lactamase-producing Enterobacteriaceae in the faecal microbiota of hospitalised patients treated with imipenem.

Grall N, Lazarevic V, Gaïa N, Couffignal C, Laouénan C, Ilic-Habensus E, Wieder I, Plesiat P, Angebault C, Bougnoux ME, Armand-Lefevre L, Andremont A, Duval X, Schrenzel J.

Int J Antimicrob Agents. 2017 Jul;50(1):81-87. doi: 10.1016/j.ijantimicag.2017.02.018. Epub 2017 May 10.

PMID:
28499958
17.

Very high prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in bacteriemic patients hospitalized in teaching hospitals in Bamako, Mali.

Sangare SA, Rondinaud E, Maataoui N, Maiga AI, Guindo I, Maiga A, Camara N, Dicko OA, Dao S, Diallo S, Bougoudogo F, Andremont A, Maiga II, Armand-Lefevre L.

PLoS One. 2017 Feb 28;12(2):e0172652. doi: 10.1371/journal.pone.0172652. eCollection 2017.

18.

Viral-bacterial coinfection affects the presentation and alters the prognosis of severe community-acquired pneumonia.

Voiriot G, Visseaux B, Cohen J, Nguyen LB, Neuville M, Morbieu C, Burdet C, Radjou A, Lescure FX, Smonig R, Armand-Lefèvre L, Mourvillier B, Yazdanpanah Y, Soubirou JF, Ruckly S, Houhou-Fidouh N, Timsit JF.

Crit Care. 2016 Oct 25;20(1):375.

19.

Prevalence of ESBL-producing Enterobacteriaceae isolated from blood cultures in Mali.

Sangare SA, Maiga AI, Guindo I, Maiga A, Camara N, Dicko OA, Diallo S, Bougoudogo F, Armand-Lefevre L, Andremont A, Maiga II.

J Infect Dev Ctries. 2016 Oct 31;10(10):1059-1064. doi: 10.3855/jidc.7536.

20.

ESBL-producing Enterobacteriaceae in travellers: doctors beware.

Armand-Lefevre L, Ruppé E, Andremont A.

Lancet Infect Dis. 2017 Jan;17(1):8-9. doi: 10.1016/S1473-3099(16)30417-0. Epub 2016 Oct 14. No abstract available.

PMID:
27751773
21.

Impact of a short exposure to levofloxacin on faecal densities and relative abundance of total and quinolone-resistant Enterobacteriaceae.

Bernard J, Armand-Lefèvre L, Luce E, El Mniai A, Chau F, Casalino E, Andremont A, Ruppé E.

Clin Microbiol Infect. 2016 Jul;22(7):646.e1-4. doi: 10.1016/j.cmi.2016.04.015. Epub 2016 Apr 26.

22.

Costs associated with implementation of a strict policy for controlling spread of highly resistant microorganisms in France.

Birgand G, Leroy C, Nerome S, Luong Nguyen LB, Lolom I, Armand-Lefevre L, Ciotti C, Lecorre B, Marcade G, Fihman V, Nicolas-Chanoine MH, Pelat C, Perozziello A, Fantin B, Yazdanpanah Y, Ricard JD, Lucet JC.

BMJ Open. 2016 Jan 29;6(1):e009029. doi: 10.1136/bmjopen-2015-009029.

23.

Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated from blood cultures in Africa.

Sangare SA, Maiga AI, Guindo I, Maiga A, Camara N, Savadogo S, Diallo S, Bougoudogo F, Armand-Lefevre L, Andremont A, Maiga II.

Med Mal Infect. 2015 Sep;45(9):374-82. doi: 10.1016/j.medmal.2015.08.003. Review.

PMID:
26433872
24.

Sternal Wound Infection after Cardiac Surgery: Management and Outcome.

Dubert M, Pourbaix A, Alkhoder S, Mabileau G, Lescure FX, Ghodhbane W, Belorgey S, Rioux C, Armand-Lefèvre L, Wolff M, Raffoul R, Nataf P, Yazdanpanah Y, Lucet JC.

PLoS One. 2015 Sep 30;10(9):e0139122. doi: 10.1371/journal.pone.0139122. eCollection 2015.

25.

Reply to Collignon and Kennedy.

Ruppé E, Armand-Lefèvre L, Estellat C, Coignard B, Lucet JC, Andremont A, Matheron S.

Clin Infect Dis. 2015 Dec 1;61(11):1767. doi: 10.1093/cid/civ705. Epub 2015 Aug 13. No abstract available.

PMID:
26276883
26.

Endocarditis due to gram-negative bacilli at a French teaching hospital over a 6-year period: clinical characteristics and outcome.

Loubet P, Lescure FX, Lepage L, Kirsch M, Armand-Lefevre L, Bouadma L, Lariven S, Duval X, Yazdanpanah Y, Joly V.

Infect Dis (Lond). 2015;47(12):889-95. Epub 2015 Aug 11.

PMID:
26260729
27.

Empirical therapies among adults hospitalized for community-acquired upper urinary tract infections: A decision-tree analysis of mortality, costs, and resistance.

Parienti JJ, Lucet JC, Lefort A, Armand-Lefèvre L, Wolff M, Caron F, Cattoir V, Yazdanpanah Y.

Am J Infect Control. 2015 Sep 1;43(9):e53-9. doi: 10.1016/j.ajic.2015.05.033. Epub 2015 Jul 6.

PMID:
26159501
28.

Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric).

Bretonnière C, Leone M, Milési C, Allaouchiche B, Armand-Lefevre L, Baldesi O, Bouadma L, Decré D, Figueiredo S, Gauzit R, Guery B, Joram N, Jung B, Lasocki S, Lepape A, Lesage F, Pajot O, Philippart F, Souweine B, Tattevin P, Timsit JF, Vialet R, Zahar JR, Misset B, Bedos JP; Société de Réanimation de Langue Française (SRLF); Société Française d’Anesthésie et de Réanimation (SFAR).

Intensive Care Med. 2015 Jul;41(7):1181-96. doi: 10.1007/s00134-015-3853-7. Epub 2015 Jun 3.

PMID:
26077053
29.

Audit of carbapenem prescriptions comparing 2 assessment periods.

Lefébure A, Papy E, Rioux C, Diamantis S, Armand-Lefèvre L, Longuet P, Lescure FX, Wolff M, Arnaud P, Lucet JC.

Med Mal Infect. 2015 Jul;45(7):273-8. doi: 10.1016/j.medmal.2015.04.008. Epub 2015 Jun 3.

PMID:
26047686
30.

High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics.

Ruppé E, Armand-Lefèvre L, Estellat C, Consigny PH, El Mniai A, Boussadia Y, Goujon C, Ralaimazava P, Campa P, Girard PM, Wyplosz B, Vittecoq D, Bouchaud O, Le Loup G, Pialoux G, Perrier M, Wieder I, Moussa N, Esposito-Farèse M, Hoffmann I, Coignard B, Lucet JC, Andremont A, Matheron S.

Clin Infect Dis. 2015 Aug 15;61(4):593-600. doi: 10.1093/cid/civ333. Epub 2015 Apr 22.

PMID:
25904368
31.

Sternal wound infection after cardiac surgery: incidence and risk factors according to clinical presentation.

Lemaignen A, Birgand G, Ghodhbane W, Alkhoder S, Lolom I, Belorgey S, Lescure FX, Armand-Lefevre L, Raffoul R, Dilly MP, Nataf P, Lucet JC.

Clin Microbiol Infect. 2015 Jul;21(7):674.e11-8. doi: 10.1016/j.cmi.2015.03.025. Epub 2015 Apr 14.

32.

Staphylococcus aureus healthcare associated bacteraemia: An indicator of catheter related infections.

Bonnal C, Birgand G, Lolom I, Diamantis S, Dumortier C, L'Heriteau F, Armand-Lefevre L, Lucet JC.

Med Mal Infect. 2015 Mar;45(3):84-8. doi: 10.1016/j.medmal.2015.01.002. Epub 2015 Feb 9.

PMID:
25676476
33.

Performance and impact of a rapid method combining mass spectrometry and direct antimicrobial susceptibility testing on treatment adequacy of patients with ventilator-associated pneumonia.

Le Dorze M, Gault N, Foucrier A, Ruppé E, Mourvillier B, Woerther PL, Birgand G, Montravers P, Dilly MP, Tubach F, Andremont A, Timsit JF, Wolff M, Armand-Lefèvre L.

Clin Microbiol Infect. 2015 May;21(5):468.e1-6. doi: 10.1016/j.cmi.2014.12.007. Epub 2014 Dec 26.

34.

Impact of imipenem and amikacin pharmacokinetic/pharmacodynamic parameters on microbiological outcome of Gram-negative bacilli ventilator-associated pneumonia.

Pajot O, Burdet C, Couffignal C, Massias L, Armand-Lefevre L, Foucrier A, Da Silva D, Lasocki S, Laouénan C, Mentec H, Mentré F, Wolff M.

J Antimicrob Chemother. 2015 May;70(5):1487-94. doi: 10.1093/jac/dku569. Epub 2015 Jan 27.

PMID:
25630642
35.

First reported human case of native mitral infective endocarditis caused by Streptococcus canis.

Amsallem M, Iung B, Bouleti C, Armand-Lefevre L, Eme AL, Touati A, Kirsch M, Duval X, Vahanian A.

Can J Cardiol. 2014 Nov;30(11):1462.e1-2. doi: 10.1016/j.cjca.2014.07.013. Epub 2014 Jul 17.

PMID:
25442453
36.

Prolonged hospital stay, an adverse effect of strict national policy for controlling the spread of highly resistant microorganisms.

Birgand G, Schwarzinger M, Perozziello A, Lolom I, Pelat C, Armand-Lefevre L, Buzzi JC, Andremont A, Yazdanpanah Y, Lucet JC.

Infect Control Hosp Epidemiol. 2014 Nov;35(11):1427-9. doi: 10.1086/678425. Epub 2014 Oct 2. No abstract available.

PMID:
25333442
37.

Population pharmacokinetics of single-dose amikacin in critically ill patients with suspected ventilator-associated pneumonia.

Burdet C, Pajot O, Couffignal C, Armand-Lefèvre L, Foucrier A, Laouénan C, Wolff M, Massias L, Mentré F.

Eur J Clin Pharmacol. 2015 Jan;71(1):75-83. doi: 10.1007/s00228-014-1766-y. Epub 2014 Oct 21.

38.

Introduction of highly resistant bacteria into a hospital via patients repatriated or recently hospitalized in a foreign country.

Birgand G, Armand-Lefevre L, Lepainteur M, Lolom I, Neulier C, Reibel F, Yazdanpanah Y, Andremont A, Lucet JC.

Clin Microbiol Infect. 2014 Nov;20(11):O887-90. doi: 10.1111/1469-0691.12604. Epub 2014 Mar 21.

39.

Population pharmacokinetics of imipenem in critically ill patients with suspected ventilator-associated pneumonia and evaluation of dosage regimens.

Couffignal C, Pajot O, Laouénan C, Burdet C, Foucrier A, Wolff M, Armand-Lefevre L, Mentré F, Massias L.

Br J Clin Pharmacol. 2014 Nov;78(5):1022-34. doi: 10.1111/bcp.12435.

40.

Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013.

Ruppé E, Armand-Lefèvre L, Estellat C, El-Mniai A, Boussadia Y, Consigny PH, Girard PM, Vittecoq D, Bouchaud O, Pialoux G, Esposito-Farèse M, Coignard B, Lucet JC, Andremont A, Matheron S.

Euro Surveill. 2014 Apr 10;19(14). pii: 20768.

41.

A retrospective study of daptomycin use in a Paris teaching-hospital.

Marc F, Esquirol C, Papy E, Longuet P, Armand-Lefevre L, Rioux C, Diamantis S, Dumortier C, Bourgeois-Nicolaos N, Lucet JC, Wolff M, Arnaud P.

Med Mal Infect. 2014 Jan;44(1):25-31. doi: 10.1016/j.medmal.2013.11.002. Epub 2013 Dec 13.

PMID:
24332833
42.

Enterobacteriaceae bacteremia: risk factors for ESBLPE.

Neulier C, Birgand G, Ruppé É, Armand-Lefèvre L, Lolom I, Yazdanpanah Y, Lucet JC, Andremont A.

Med Mal Infect. 2014 Jan;44(1):32-8. doi: 10.1016/j.medmal.2013.11.003. Epub 2013 Dec 8.

PMID:
24321202
43.

Rapid detection of glycopeptide-resistant enterococci: impact on decision-making and costs.

Birgand G, Ruimy R, Schwarzinger M, Lolom I, Bendjelloul G, Houhou N, Armand-Lefevre L, Andremont A, Yazdanpanah Y, Lucet JC.

Antimicrob Resist Infect Control. 2013 Nov 4;2(1):30. doi: 10.1186/2047-2994-2-30.

44.

Relative fecal abundance of extended-spectrum-β-lactamase-producing Escherichia coli strains and their occurrence in urinary tract infections in women.

Ruppé E, Lixandru B, Cojocaru R, Büke C, Paramythiotou E, Angebault C, Visseaux C, Djuikoue I, Erdem E, Burduniuc O, El Mniai A, Marcel C, Perrier M, Kesteman T, Clermont O, Denamur E, Armand-Lefèvre L, Andremont A.

Antimicrob Agents Chemother. 2013 Sep;57(9):4512-7. doi: 10.1128/AAC.00238-13. Epub 2013 Jul 8.

45.

Time-to-positivity-based discrimination between Enterobacteriaceae, Pseudomonas aeruginosa and strictly anaerobic Gram-negative bacilli in aerobic and anaerobic blood culture vials.

Defrance G, Birgand G, Ruppé E, Billard M, Ruimy R, Bonnal C, Andremont A, Armand-Lefèvre L.

J Microbiol Methods. 2013 May;93(2):77-9. doi: 10.1016/j.mimet.2013.02.005. Epub 2013 Feb 28.

PMID:
23454787
46.

Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients.

Armand-Lefèvre L, Angebault C, Barbier F, Hamelet E, Defrance G, Ruppé E, Bronchard R, Lepeule R, Lucet JC, El Mniai A, Wolff M, Montravers P, Plésiat P, Andremont A.

Antimicrob Agents Chemother. 2013 Mar;57(3):1488-95. doi: 10.1128/AAC.01823-12. Epub 2013 Jan 14.

47.

Duration of colonization by extended-spectrum β-lactamase-producing Enterobacteriaceae after hospital discharge.

Birgand G, Armand-Lefevre L, Lolom I, Ruppe E, Andremont A, Lucet JC.

Am J Infect Control. 2013 May;41(5):443-7. doi: 10.1016/j.ajic.2012.05.015. Epub 2012 Sep 19.

PMID:
22998785
48.

Diversity of extended-spectrum β-lactamase-producing Enterobacteriaceae on hospital admission.

Roux D, Huy C, Lolom I, Andremont A, Arlet G, Armand-Lefevre L, Lucet JC.

Scand J Infect Dis. 2012 Mar;44(3):231-6. doi: 10.3109/00365548.2011.623314. Epub 2011 Nov 8.

PMID:
22066775
49.

Massive increase, spread, and exchange of extended spectrum β-lactamase-encoding genes among intestinal Enterobacteriaceae in hospitalized children with severe acute malnutrition in Niger.

Woerther PL, Angebault C, Jacquier H, Hugede HC, Janssens AC, Sayadi S, El Mniai A, Armand-Lefèvre L, Ruppé E, Barbier F, Raskine L, Page AL, de Rekeneire N, Andremont A.

Clin Infect Dis. 2011 Oct;53(7):677-85. doi: 10.1093/cid/cir522.

PMID:
21890771
50.

Development of a phenotypic method for detection of fecal carriage of OXA-48-producing enterobacteriaceae after incidental detection from clinical specimen.

Ruppé E, Armand-Lefèvre L, Lolom I, El Mniai A, Muller-Serieys C, Ruimy R, Woerther PL, Bilariki K, Marre M, Massin P, Andremont A, Lucet JC.

J Clin Microbiol. 2011 Jul;49(7):2761-2. doi: 10.1128/JCM.00055-11. Epub 2011 May 11.

Supplemental Content

Loading ...
Support Center